Blood Biomarkers for Large Vessel Occlusions: A Systematic Review

The review highlights the critical role of biomarker blood testing to enhance LVO diagnosis, especially in acute clinical settings. Coagulation and hemostasis markers such as D-dimer offer rapid thrombus detection, and acute brain injury and angiogenic biomarkers provide insight into the extent of injury, localization, and vascular response. A combination of biomarkers from multiple categories is needed to provide an accurate clinical picture of LVO in patients. Excluding studies on embolic strokes, including cardioembolic subtypes, may also bias findings by neglecting their distinct biomarker profiles, warranting further investigation to fully assess biomarker utility across stroke etiologies. Despite promising results for multiple biomarkers, including glial fibrillary acidic protein, ubiquitin C-terminal hydrolase-L1, and D-dimer, further research is needed to validate these biomarkers in diverse populations and integrate them into clinical practice effectively.

Authors

Institutions

Publication Details

Journal
Stroke Vascular and Interventional Neurology
Published
2025-11-01
DOI
https://doi.org/10.1161/svin.125.001863
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Blood Biomarkers for Large Vessel Occlusions: A Systematic Review

Joshua S. Catapano, Kyle W. Scott, Scott Eric Kasner, Visish Mani Srinivasan et al.
Stroke Vascular and Interventional Neurology
Acute Ischemic Stroke Management
article

Blood Biomarkers for Large Vessel Occlusions: A Systematic Review

Joshua S. Catapano, Kyle W. Scott, Scott Eric Kasner, Visish Mani Srinivasan, Rashad Jabarkheel, Jan‐Karl Burkhardt, Ruchira Menka Jha, Shray Patel, Avi A. Gajjar, Adam T. Eberle, Oscar A. Marcos‐Contreras, Saarang Patel, Ganesh Chilukuri, Bryan Pukenas, Ilayda Kayir, T Italia
article en

Abstract

The review highlights the critical role of biomarker blood testing to enhance LVO diagnosis, especially in acute clinical settings. Coagulation and hemostasis markers such as D-dimer offer rapid thrombus detection, and acute brain injury and angiogenic biomarkers provide insight into the extent of injury, localization, and vascular response. A combination of biomarkers from multiple categories is needed to provide an accurate clinical picture of LVO in patients. Excluding studies on embolic strokes, including cardioembolic subtypes, may also bias findings by neglecting their distinct biomarker profiles, warranting further investigation to fully assess biomarker utility across stroke etiologies. Despite promising results for multiple biomarkers, including glial fibrillary acidic protein, ubiquitin C-terminal hydrolase-L1, and D-dimer, further research is needed to validate these biomarkers in diverse populations and integrate them into clinical practice effectively.

Stroke Vascular and Interventional NeurologyVol. 5(6)
Bahçeşehir University (TR), St. Joseph's Hospital and Medical Center (US), Thomas Jefferson University (US), Hospital of the University of Pennsylvania (US), California University of Pennsylvania (US), Translational Therapeutics (United States) (US), Drexel University (US), University of Pennsylvania (US)
Openalex Percentile: Top 55%
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.